(Q72211763)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8094999%20AND%20SRC:MED&resulttype=core&format=json

24 October 2019

title

Induction of antitumor L3T4-positive T cells by OK-432 at tumor sites in mice (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8094999%20AND%20SRC:MED&resulttype=core&format=json

24 October 2019

author name string

Y Moriya

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8094999%20AND%20SRC:MED&resulttype=core&format=json

24 October 2019

H Sato

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8094999%20AND%20SRC:MED&resulttype=core&format=json

24 October 2019

K Ito

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8094999%20AND%20SRC:MED&resulttype=core&format=json

24 October 2019

M Saito

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8094999%20AND%20SRC:MED&resulttype=core&format=json

24 October 2019

T Yoshida

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8094999%20AND%20SRC:MED&resulttype=core&format=json

24 October 2019

N Ishida

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8094999%20AND%20SRC:MED&resulttype=core&format=json

24 October 2019

publication date

1 January 1993

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8094999%20AND%20SRC:MED&resulttype=core&format=json

Cancer Immunology, Immunotherapy

24 October 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8094999%20AND%20SRC:MED&resulttype=core&format=json

24 October 2019

volume

36

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8094999%20AND%20SRC:MED&resulttype=core&format=json

24 October 2019

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8094999%20AND%20SRC:MED&resulttype=core&format=json

24 October 2019

page(s)

245-250

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8094999%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/bf01740906

24 October 2019

exact match

0 references

cites work

Biological response modifier as antigen: OK432-specific T-cell clone as an anti-tumor effector cell

1 reference

12 December 2020

Antitumor activity of murine neutrophils demonstrated by cytometric analysis

1 reference

12 December 2020

The activation of L3T4+ helper T cells assisting the generation of anti-tumor Lyt-2+ cytotoxic T lymphocytes: requirement of Ia-positive antigen-presenting cells for processing and presentation of tumor antigens

1 reference

12 December 2020

Studies on macrophage-activating factor (MAF) in antitumor immune responses. I. Tumor-specific Lyt-1+2- T cells are required for producing MAF able to generate cytolytic as well as cytostatic macrophages

1 reference

12 December 2020

Cloned helper T cells can kill B lymphoma cells in the presence of specific antigen: Ia restriction and cognatevs. noncognate interactions in cytolysis

1 reference

12 December 2020

Clinical value of immunotherapy for lung cancer by the streptococcal preparation OK-432

1 reference

12 December 2020

Adoptive immunotherapy by pantropic killer cells recovered from OK-432-injected tumor sites in mice

1 reference

12 December 2020

Induction of tumoricidal activity of polymorphonuclear leukocytes by a linear beta-1,3-D-glucan and other immunomodulators in murine cells

1 reference

12 December 2020

The preclinical screening laboratory: evaluation of immunomodulatory and therapeutic properties of biological response modifiers

1 reference

12 December 2020

In vivo antitumor effect of lymphokine-activated rodent polymorphonuclear leukocytes

1 reference

12 December 2020

Pronounced antitumor effect of LAK-like cells induced in the peritoneal cavity of mice after intraperitoneal injection of OK-432, a killed streptococcal preparation.

1 reference

12 December 2020

Lysis of fresh human tumor cells by autologous peripheral blood lymphocytes and pleural effusion lymphocytes activated by OK432

1 reference

12 December 2020

New approach to management of malignant ascites with a streptococcal preparation, OK-432. I. Improvement of host immunity and prolongation of survival

1 reference

12 December 2020

Cytotoxic cells induced in tumor-bearing rats by a streptococcus preparation (OK-432)

1 reference

12 December 2020

CD4+ T cell-mediated killing of MHC class II-positive antigen-presenting cells. I. Characterization of target cell recognition by in vivo or in vitro activated CD4+ killer T cells

1 reference

12 December 2020

Clinical studies on cell-mediated immunity in patients with malignant disease. I. Effect of immunotherapy with OK-432 on lymphocyte subpopulation and phytomitogen responsiveness in vitro

1 reference

12 December 2020

The role of L3T4-positive T lymphocytes in the generation of anti-tumor immunity in the mouse

1 reference

12 December 2020

Hapten-specific, class II-restricted killing by cloned T cells: direct lysis and production of a cytotoxic factor

1 reference

12 December 2020

Activated macrophages are responsible for the tumor-inhibitory effect in mice receiving intravenous injection of OK-432

1 reference

12 December 2020

New approach to management of malignant ascites with a streptococcal preparation, OK-432. II. Intraperitoneal inflammatory cell-mediated tumor cell destruction

1 reference

12 December 2020

Activation of cytotoxic polymorphonuclear leukocytes by in vivo administration of a streptococcal preparation, OK-432

1 reference

12 December 2020

Role of inflammatory neutrophils in antitumor effects induced by intraperitoneal administration of Corynebacterium parvum in mice

1 reference

12 December 2020

Cytolytic activity of antigen-specific T cells with helper phenotype

1 reference

12 December 2020

Bispecific Antibody-directed Antitumor Activity of Human CD4+Helper/Killer T Cells Induced by Anti-CD3 Monoclonal Antibody plus Interleukin 2

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF01740906

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8094999%20AND%20SRC:MED&resulttype=core&format=json

24 October 2019

1 reference